Nuntius Therapeutics Analysis: $0.1M Raised
What is Nuntius Therapeutics?
Nuntius Therapeutics specializes in developing transformative mRNA therapies using proprietary delivery technology. Their innovative approach leverages machine learning and advanced nucleic acid engineering to enhance therapeutic efficacy. This enables targeted treatments for life-threatening diseases, significantly improving patient outcomes.
HQ Country
London, United Kingdom
Employees
1-10
Founded
2021
Industry
Biotech, HealthTech, AI/ML
Product Features & Capabilities
- Programmable nanocarriers for targeted mRNA delivery
- Machine learning models for carrier performance prediction
- Advanced mRNA engineering for superior protein expression
- Drug development pipeline for cancer and lung diseases
- Collaboration with Taiho Pharmaceutical for mRNA cancer therapies.
How much Nuntius Therapeutics raised
1 - $125,000
March 22, 2021Lead Investor: Asymmetry Ventures, Backed VC, FoundersX Ventures, Uncommon Denominator
